Favour­ing Ja­pan

BioSpectrum (Asia) - - Bio Edit -

Ja­pan is def­i­nitely be­com­ing a lu­cra­tive mar­ket for biosim­i­lars mak­ers. Please do cover sim­i­lar trend for other coun­tries as well. Ac­qui­si­tions are also part of the com­plex gener­ics devel­op­ment game. Look­ing for­ward to more such articles.

- Nitin Rao, Mum­bai

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.